Search

Your search keyword '"Onal, Cem"' showing total 5 results
Start Over Author "Onal, Cem" Journal european urology oncology
5 results on '"Onal, Cem"'

2. Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002

Author

Guler, Ozan Cem, primary and Onal, Cem, additional

Published
2022
Full Text
View/download PDF

4. Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer

Author

Sutera, Philip, Song, Yang, Shetty, Amol C., English, Keara, Van der Eecken, Kim, Guler, Ozan Cem, Wang, Jarey, Cao, Yufeng, Bazyar, Soha, Verbeke, Sofie, Van Dorpe, Jo, Fonteyne, Valérie, De Laere, Bram, Mishra, Mark, Rana, Zaker, Molitoris, Jason, Ferris, Matthew, Kiess, Ana, Song, Daniel Y., DeWeese, Theodore, Pienta, Kenneth J., Barbieri, Christopher, Marchionni, Luigi, Ren, Lei, Sawant, Amit, Simone, Nicole, Berlin, Alejandro, Onal, Cem, Tran, Phuoc T., Ost, Piet, and Deek, Matthew P.

Abstract

For patients with metachronous oligometastatic castration-sensitive prostate cancer, tumor genomics may play a role in the mode of progression and pattern of failure after initial therapy for metastatic disease. Specifically, patients with TP53and RB1mutations have a higher likelihood of progression, and TP53, SPOP, and WNT pathway mutations may have a role in metastatic organotropism directing the likelihood of bone and visceral disease progression.

Published
2024
Full Text
View/download PDF

5. Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68 Ga-Prostate-specific Membrane Antigen and 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002.

Author

Guler OC and Onal C

Subjects
Androgen Antagonists therapeutic use, Androgens, Fluorodeoxyglucose F18, Gallium Radioisotopes, Humans, Male, Positron Emission Tomography Computed Tomography methods, Prospective Studies, Prostate pathology, Prostate-Specific Antigen, Prostatic Neoplasms pathology, Prostatic Neoplasms therapy
Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results